0001213900-21-020638.txt : 20210407
0001213900-21-020638.hdr.sgml : 20210407
20210407160823
ACCESSION NUMBER: 0001213900-21-020638
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210205
FILED AS OF DATE: 20210407
DATE AS OF CHANGE: 20210407
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ong Tuyen
CENTRAL INDEX KEY: 0001673178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39438
FILM NUMBER: 21812205
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gemini Therapeutics, Inc. /DE
CENTRAL INDEX KEY: 0001816736
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851613057
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (617) 401-4400
MAIL ADDRESS:
STREET 1: 300 ONE KENDALL SQUARE, 3RD FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: FS Development Corp.
DATE OF NAME CHANGE: 20200702
4
1
ownership.xml
X0306
4
2021-02-05
0
0001816736
Gemini Therapeutics, Inc. /DE
GMTX
0001673178
Ong Tuyen
C/O GEMINI THERAPEUTICS, INC.
300 ONE KENDALL SQUARE, 3RD FLOOR
CAMBRIDGE,
MA
02139
1
0
0
0
Stock Option (Right to Buy)
12.66
2021-02-05
4
A
0
58855
0
A
2031-02-04
Common Stock
58855
58855
D
This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 5, 2021 with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a Service Relationship with the Company.
/s/ Jason Meyenburg, attorney-in-fact
2021-04-07